Market Research Blog – Page 15864 – New Product Development

Controlled and Slow Release Fertilizers Market is expected to reach US$ 10.1 Bn by the end of 2028, Says FMI Analyst

FMI presents detailed analysis and delivers key insights on the global controlled and slow release fertilizers market in its latest report titled ‘Controlled and Slow Release Fertilizers Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028’. The long-term outlook on the global controlled and slow release fertilizers market is positive with the controlled and slow release fertilizers market pegged at a value of US$ 4,791 Mn in 2018. It is expected to reach US$ 10,222.4 Mn by 2028 end, growing at a value CAGR of 9.1%. Among the segments by type, the encapsulated/coated controlled and slow release fertilizers segment is expected account for the lion’s share in terms of value and volume over the forecast period. The encapsulated/coated controlled and slow release fertilizers segment is expected to expand at a relatively higher CAGR. Among regions, Asia Pacific excluding Japan (APEJ) is anticipated to retain its dominance throughout the forecast period while growing at a rate of 11.1% from 2018 to 2028. In this report, FMI throws light on the drivers and restraints likely to impact the controlled and slow release fertilizers market during this period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1559

Global Controlled and Slow Release Fertilizers Market Dynamics

Market insights suggest that the global controlled and slow release fertilizers market will witness high growth during the forecast period, which can be attributed to the growing population and decreasing agricultural land. Growing food consumption and increasing need for effective fertilizers are pushing the market for controlled and slow release fertilizers. The need for higher output with fewer resources is the driving the development of new technologies in the agricultural industry. With the use of conventional fertilizers, it is not possible to satisfy the growing demand for food. The use of slow and controlled release fertilizers improves the yield and saves labour. New developments such as increase in the longevity and performance of coated fertilizers are pushing the market for controlled and slow release fertilizers in agricultural as well as commercial applications. The slow release of nutrients allows fertilizers to last longer and thereby increase fertilizer performance, which is driving the demand for controlled and slow release fertilizers.

Urea reaction products also accounted for a significant share of the controlled and slow release fertilizers market; however, the increasing popularity of encapsulated coated fertilizers is expected to dominate the urea reaction product segment during the forecast period. The superior longevity of encapsulated/coated products as compared to that of urea reaction products is expected to push the growth of the encapsulated/ coated segment during the forecast.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-1559

Global Controlled and Slow Release Fertilizers Market Segmentation Analysis

The controlled and slow release fertilizers market has been segmented on the basis of application into agricultural, commercial lawn and turf and others.

On the basis of application, the agricultural segment is anticipated to dominate the controlled and slow release fertilizers market in terms of value and volume over the forecast period
The agricultural segment is also projected to grow at a relatively higher CAGR over the forecast period. It is expected to represent a total incremental opportunity of US$ 3,863 Mn between 2018 and 2028 in the global controlled and slow release fertilizers market

Global Controlled and Slow Release Fertilizers Market Regional Forecast

Regionally, APEJ accounted for over 47% of the global controlled and slow release fertilizers market value while North America accounted for the second largest share in the controlled and slow release fertilizers market. APEJ is projected to be the fastest growing region with a CAGR of 11.5% during the forecast period. Large population base and rapid population growth, improving economic conditions, change in eating habits and increasing food consumption are some of the important factors driving the demand for controlled and slow release fertilizers.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-1559

Global Controlled and Slow Release Fertilizers Market Competition Landscape

The report highlights some of the top companies operating in the global controalled and slow release fertilizers market, including Kingenta Ecological Engineering Group Co. Ltd., Israel Chemicals Ltd (ICL), Yara International ASA, Agrium Inc., Haifa Chemicals Ltd., Koch Fertilizer LLC and Aglukon Spezialduenger GmbH & Co. KG., among others.

For more information, reach out to Future Market Insights analysts at press@futuremarketinsights.com

Calcite Market Trends 2022 | Segmentation, Outlook, Industry Report to 2031

The growing demand for building or structure safety measures across residential, commercial and industrial sectors are key factors driving the global calcite market. According to a study by Future Market Insights (FMI), calcite sales will continue rising in response to increasing industrial applications and rising construction activities. According to FMI, the market will surpass US$ 15.14 Bn by 2021.

The demand for ground calcium carbonate or GCC calcite will remain significantly high. It is expected account for over 60% of calcite sold globally in 2021. Increasing demand for cement has resulted in significant growth in demand for calcite. Besides this, the demand from paper and pulp industry will enable the market exhibit consistent growth through the forecast period.

The global calcite market is anticipated to grow owing to the increasing investment towards residential and commercial construction. Besides this rapid urbanization will pave way for the expansion of the market. This is especially true in case of developing countries in the East. Following temporary period of sluggish growth amid COVID-19, construction sector revival is on cards for countries such as India and China.

According to the Invest India, the construction industry in India is expected to record a CAGR of 15.7% by 2022. Considering this, India will continue presenting lucrative growth opportunities for the market through the forecast period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3797

Key Takeaways of Global Calcite Market Study

The U.S. will account for over 80% of the North America calcite market in 2021
The overall value of the calcite market in the U.K. will surpass US$ 560 Mn in 2021
France and Germany will remain lucrative markets for calcite backed by increasing construction activities
Surging investment in infrastructural development will continue fuelling demand in Japan and South Korea

“As a result of operating in a highly competitive environment, market players have been focusing on product improvement and launches as key strategies to gain competitive edge. Besides this, some of them are seeking out strategic collaborations to expand their footprint as well as product portfolio” says a lead FMI analyst.

Market Landscape Continues to Remain Moderately Fragmented

The global calcite market has been identified as a significantly fragmented market with an unorganized sector occupying major section. The Tier 1 manufacturers account for maximum share in the global market. Some leading players included in the report are Imerys S. A., Omya AG, J. M. Huber Corporation, Minerals Technologies Inc. and Gulshan Polyol Ltd. Tier 2 manufacturers such as ASEC Company for Mining, Esen Mikronize A.S, Wolkem India Ltd., Shandong CITIC Calcium Industry Co., Ltd. and Tier 3 manufacturers such as Columbia River Carbonates, Jay Minerals, Golden Lime Public Co., Ltd., Longcliffe Quarries Ltd., Vietnam CMT Joint Stock Company, Mississippi Lime Company and many regional players’ manufacturers across the globe are anticipated to create tough competitive environment on the global level.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-3797

How is Calcite Sale Affected by Applications in Construction Industry?

The growth in the construction industry is expected to have high impact on the demand for calcite in the building materials market. The demand for building materials is increasing due to the ongoing constructions activities in both commercial and residential sectors. The cement production has been increasing significantly in recent years owing to the high investment in infrastructure development activities.

This has emerged as a chief factor fuelling the demand for calcite in countries such as China, UAE, Saudi Arabia, India, and others. Thus, the increasing use of building materials and cement in these countries will significantly affect calcite market growth

Want to Know More?

Future Market Insights, in its new report, offers an unbiased analysis of the global calcite market, analysing historical demand from 2016-2020 and forecast statistics for 2021–2031. The study reveals growth projections on the calcite market on the basis of type (GCC and PCC), by size (coarse and fine), and by applications (pulp & paper, polymer & plastic, paints & coatings, cement, adhesives & sealants, and agriculture) across key regions (North America, Latin America, Europe, South Asia & Pacific, East Asia, Middle East and Africa)

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-3797

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Fly Ash Bricks Market Research Report 2022 – Global Forecast till 2026

Fly ash bricks as the name signifies, is made from fly ash generated from the thermal power stations along with lime and gypsum. Pulverized fuel ash is called fly ash and is mostly generated from thermal power stations where it is generated by burning of coal. The fly ash bricks requires almost 25-30% less cement or motor. These bricks are made from machines, hence, they are uniform in shape and size and can be easily arranged in symmetrical structures providing immense strength and bonding. The outside cement wall plastering is not required in case of fly ash bricks as they are grey and have smooth and uniform texture and these bricks absorb significantly less water. These are much lighter in weight as compared to conventionally used red bricks thereby reducing the transportation and dead building costs. Moreover, fly ash bricks do not require firing which is an important manufacturing step for the red bricks and therefore does not contribute to environmental pollution.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7189

Global Fly Ash Bricks Market: Regional Outlook

The global fly ash bricks market is anticipated to be dominated by Asia Pacific region. China and India are projected to witness significant growth rate over the forecast period, owing to the investments and growing construction spending which has led to rapid industrial and infrastructural developments. North America and Europe are projected to hold significant share in the global fly ash market. However, the regions are projected to witness relatively moderate growth owing to the stringent policies and regulations for the harmful effect of fly ash and the decrease in raw material availability due to decreasing number of thermal power plants.

Global Fly Ash Bricks Market Participants

Some of the market participants identified across the value chain of global Ballast Tank Corrosion Inhibitors market are:

Boral Limited
EMEX S.A.B. DE C.V
Pavcon
Nuvoco Vistas Corp Ltd.
LafargeHolcim
Jayem Manufacturing Co.
MR Enterprises
Puzzolana Green Bricks
Jebajeyam Brick Company
Paul Bricks
Pyramid Chemicals (P) Ltd
HansonDoha
NCL Group

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7189

Global Fly Ash Bricks Market Segmentation

The global fly ash bricks market can be segmented on the basis of product type, application and region

On the basis of product type, the global fly ash bricks market can be segmented as:

Class F Fly ash
Class C Fly Ash

On the basis of end use sector, the global fly ash bricks market can be segmented as:

Infrastructural
Industrial
Residential

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-7189

About Future Market Insights (FMI)

Ceramic Frit Market 2022 Key Players, SWOT Analysis, Key Indicators and Forecast to 2028

Ceramic frit is a composition of multiple raw materials, mostly of inorganic origin, and is produced by melting and quenching in water. Ceramic frit compounds are vitreous and water insoluble. Ceramic frit is fused in a special oven, and granulated into powder form after being cooled and quenched in water. Ceramic frit is a key component used in the compounding of ceramic glazes and enamels. There a various benefits of using ceramic frit in glazes and enamels. Ceramic frit serves the purpose of rendering insolubility to soluble materials in a glaze mixture. This provides protection against bloating and warping and compromising the glaze’s homogeneous nature. The process of “fritting” using ceramic frit compositions reduces or completely negates the harmful effects of toxic raw materials. Ceramic frit helps protect workers and improve process safety by decreasing the toxicity of raw materials. For example, lead being a part of raw materials creates dangers of poisoning and toxicity for ceramic workers.

However, lead ceramic frit decreases the overall toxicity of raw lead. Moreover, ceramic frit has much better consistency for glaze production compared to individual raw materials, who may have significantly different chemical and physical properties. Ceramic frit is widely used in the glass industry. Manufacturing ceramic frit glass involves applying ceramic frit to the glass using methods such as screen printing. This is done before the glass is put through the process of tempering or heat strengthening. After being tempered or heat strengthened, the ceramic frit enamel fuses with the glass surface, resulting in the creation of a permanent coating. This coating is highly resistant to damage or removal by acts such as scrubbing, scratching, or cleaning etc.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7721

Ceramic Frit Market: Regional Outlook

The demand for Ceramic Frit is set to grow at a fast pace in the next five to ten years as the demand for high quality glass, ceramic ware, and sanitary ware and solar panels grow. Asia Pacific region is expected to be significant for Ceramic Frit market, as it is witnessing rapidly increasing demand for decorative ceramic frit glass. The region also has boasts of the largest demand for solar panels and has large scale automotive production. North America is also a large market for Ceramic Frit with a robust market for architectural decoration using ceramic frit glass. The market for ceramic frit in Europe remains steady, with stable demand patterns. China, India, Japan, US, UK, Germany, are some of the key countries to watch in the Ceramic Frit market.

Ceramic Frit Market: Market Participants

Examples of some of the market participants identified in the Ceramic Frit market include,

Torrecid Group
Fusion Ceramics Inc
Garibaldi Glass Inc.
Futura Ceramics Pvt. Ltd.
Compagnie de Saint-Gobain S.A.
Multiver Ltée
Supreme Glazes Private Limited
Tokan Material Technology Co.,Ltd.
Cerfrit SA
Color Esmalt, S.A

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-7721

Ceramic Frit Market: Segmentation

On the basis of type, the Ceramic Frit market can be segmented as,

Alkaline-boron frit
Strontium-barium frit
Zinc frit
Magnesium frit
Lithium frit
Zinc free calcium frit
Boron free frit

On the basis of application, the Ceramic Frit market can be segmented as,

Glass and Decorative Glass
Abrasives & Refractories
Pottery Wares
Solar Panels
Sanitary ware
Automotive

On the basis of application method, the Ceramic Frit market can be segmented as,

Screen Printing
Spraying
Rolling
Pre-Printed Decals

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-7721

About Future Market Insights (FMI)

Digital Breast Tomosynthesis (DBT) Equipment Market size is Expected to Reach US$ 2.1 Billion in 2026

Digital breast tomosynthesis (DBT) or 3-D mammography new installations (includes new equipment and 3-D upgradation) expected to reach 4,547 units in 2016, up from 4,061 units in 2015. In terms of revenues, the global digital breast tomosynthesis equipment market is expected to reach 1,007.6 Mn in 2016, witnessing a year-over-year growth of 13.7%.

Limitations concerning the flat nature of images achieved through a 2-D full-field digital mammography (FFDM) is influencing end-users to adopt DBT equipment for diagnosis of breast cancers. Digital breast tomosynthesis enables radiologists to analyse abnormalities lucidly, helping improve detection rates while reducing callbacks. In the backdrop of these factors, demand for digital breast tomosynthesis equipment is witnessing an uptick, and the trend is expected to gain further momentum in the future.

To remain ‘ahead’ of your competitors, request for a sample

Sales of DBTs have remained quite robust in the US in the recent past, making North America the most lucrative market globally. The market in the region is largely dominated by Hologic, Inc. although GE and Siemens Healthineers have also registered their presence by launching innovative DBT products at competitive prices. Total DBT equipment revenues in North America were pegged at 472.8 Mn in 2015, with the U.S. accounting for bulk of revenue share. New equipment installation base in North America is expected to reach 2,327 in 2016, up from 2,066 in 2015.

In addition to North America, digital breast tomosynthesis sales are also growing steadily in Western Europe and APEJ. Revenues in Western Europe are anticipated to grow by 13.4% in 2016, whereas APEJ is expected to increase at 12.2%.

By end-users, hospitals account for higher demand for DBTs vis-à-vis diagnostic centres. Many hospitals are in the process of upgrading their existing mammography machines, owing to which demand for DBT equipment is growing at a steady rate. However, high costs, coupled with lack of awareness can impede adoption rates in both hospitals and diagnostic centres, and slow down the growth of the market globally. Installations of DBTs in hospitals totalled 3,020 in 2015, representing a market value worth 542.8 Mn.

Key players in the global digital breast tomosynthesis equipment market include

Hologic Inc.
GE Healthcare
Siemens Healthineers
Internazionale Medico Scientifica
Fujifilm
Planmed Oy.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1241

The top 3 players

Hologic, Inc.,
GE Healthcare,
Siemens Healthineers collectively account for nearly 90% revenue share of the market.

Drivers and Trends

Risk of developing cancer is directly proportional to age. Increasing life expectancy in developing countries and adoption of unhealthy lifestyles due to rampant urbanisation and westernisation are driving incidence rate of cancer among the population in these countries. Although, incidence of breast cancer has reduced in developed countries due to several preventive measures implemented by various government and non-governmental organisations, incidence rate of breast cancer is increasing at a steady rate.

These factors are expected to increase the prevalence and diagnosis of breast cancer over the forecast period. DBT machines, with their superior sensitivity and specificity in comparison to conventional 2D mammography, reduces false positive recalls and offers better cancer detection especially, invasive cancer detection. DBT reduces the need to revisit for additional breast imaging by around 15%, thereby reducing costs, psychological distress, time and discomfort caused by a false negative recall. DBT equipment manufacturers are providing software and hardware upgrades for existing full film digital mammography systems which addresses the financial impact of buying new equipment.

Key Segments Covered

By Product type

DBT Equipment

3-D Upgradation

By End User

Hospital

Diagnostic centres

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1241

Key Regions Covered

North America

Latin America

Western Europe

Eastern Europe

APEJ

Japan

India Thyroid Function Test Market revenues expected to surpass US$ 55.3 Million by 2025

Awareness on hyperthyroidism and hypothyroidism continues to remain low in India, resulting into fewer people undergoing thyroid function tests. The India thyroid function test market will witness moderate growth in 2016, raking in 41.6 Mn in revenues, up from US$ 40.1 Mn in 2015. While high prevalence of thyroid dysfunction and government initiatives to raise awareness will continue to support growth in 2016, stagnant R&D investment in immunochemistry will impede overall momentum.

TSH will continue to be the leading test type segment in 2016, raking in US$ 25.1 Mn in revenues, an increase of US$ 1 Mn from 2015. TSH is widely recommended as a primary test for diagnosing hypothyroidism by medical experts, contributing to higher revenues vis-à-vis T3, T4, FT3, and FT4 tests.

T4 will extend its lead over T3 test type segment, witnessing a higher y-o-y revenue growth in 2016 over 2015. T4 revenues totalled US$ 4.5 Mn in 2015, and this segment is expected to add US$ 1.7 Mn in revenues in 2016.

Parameter	2015	2016
India Market	40.1	41.6
TSH Test type Segment	24.1	25.1
T3 Test type Segment	4.5	4.6
Hospitals End-use Segment	21.3	22.2

(All values are in US$ Mn)

To remain ‘ahead’ of your competitors, request for a sample

Hospitals will continue to be the leading end-use segment for thyroid function tests, representing revenues worth US$ 22.2 Mn in 2016, up from US$ 21.3 Mn in 2015. Hospitals will be the fastest growing end-use segment, followed by research organisations and diagnostic laboratories. Clinics will remain the smallest end-use segment in 2016, witnessing lowest growth rate vis-à-vis other segments.

Long-term Outlook: FMI forecasts moderate long-term growth for the India thyroid function test market, with global revenues expected to surpass US$ 55.3 Mn by 2025. During the period 2015-2025, the India thyroid function test market is anticipated to increase at 3.2% CAGR.

Competitive Landscape

Some of the key players covered in the India thyroid function test market report include

Sigma-Aldrich Co. LLC. (Merck & Co., Inc.)
Beckman Coulter, Inc.
(Danaher)
Siemens Healthcare GmbH
Abbott Laboratories

The report offers insights on the various strategies related to software development, market consolidation initiatives and analyses the various market players’ specific strengths, weaknesses, opportunities and threats.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-IN-1531

Drivers and Trends

The cardinal factor fuelling growth of the India thyroid function test market is high prevalence of thyroid disorders in the country. During an epidemiology study across major cities in India, Kolkata was reported to have highest prevalence of hypothyroidism (21.67%) compared to other cities. Over the past few years there have been significant advancements in the specificity and sensitivity of thyroid testing, which has impacted the treatment for thyroid disorders.

The Indian healthcare industry has witnessed significant advancements with regard to medical devices and pathological laboratory business segments. Domestic and international companies are entering into joint ventures and strategic agreements owing to increasing standardization, availability of human resources and high level of progress in medical technology.

India is witnessing various trends that are expected to bring substantial changes in the landscape of the healthcare industry in the subsequent years. Traditional health risks have been replaced by lifestyle diseases in the last two decades. Various conditions prevailing currently include hypothyroidism, cardiovascular disorders, diabetes, obesity and hypertension to name a few

Key Segments Covered

By Test type

TSH
T3
T4
FT3
FT4
Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-in-1531

By End Use

Clinics
Research Organizations
Diagnostic Laboratories
Hospitals

Wound Irrigation Systems Market is expected to grow at the fastest pace to reach a CAGR of 4.7% during the forecast 2021 – 2027

The report on the global wound irrigation systems market covers annual sales revenue generated by various market segments during the period of assessment 2017-2027. Furthermore, developments taking place in the market, various trends impacting the market and other drivers fuelling the growth of the global wound irrigation systems market are enumerated in this research. Also few challenges that are pulling market growth southward are also assessed. The research report titled “Wound Irrigation Systems Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” presents a complete high level overview of the market to the reader and supports strategic plans for future moves by portraying an accurate forecast model of the global wound irrigation systems market.

Global Market Study on Wound Irrigation Systems: Factors Impacting Revenue Growth of the Global Market

There are various aspects influencing the growth of the global wound irrigation systems market in a positive as well as in a negative manner. Factors such as increasing initiatives by healthcare facilities, availability of improved product lines for wound care, increasing prevalence of chronic wounds and increasing adoption of advanced wound care products are pushing the growth of the global market for wound irrigation systems. Factors such as relatively higher costs associated with advanced wound care products and limited awareness among the rural population are hindering the growth of the global wound irrigation systems market. The market has also witnessed few trends that are likely to define the market’s growth in the coming years. Increasing acceptance of standardised protocols to manage complex wounds and collaborative agreements between manufacturers and channel partners are few of the trends that are contributing to the growth of the global wound irrigation systems market.

To remain ‘ahead’ of your competitors, request for a sample

Global Market Study on Wound Irrigation Systems: Forecast Analysis

The global wound irrigation systems market is expected to grow at a slow rate to register a CAGR of 3.0% throughout the period of assessment and reach a valuation of more than US$ 300 Mn by the end of the year of assessment from a value of about US$ 230 Mn in 2017.

Global Market Study on Wound Irrigation Systems: Segmental Snapshot

The global wound irrigation systems market is segmented by product type, by wound type, by end user and by region.

By product type, the battery operated segment is the largest with a high market valuation. The manually operated segment, however, is gaining traction and is poised to grow at a comparatively high CAGR throughout the period of forecast

By wound type, the chronic wounds segment is projected to grow at a high CAGR of 3.5% during the forecast period. The acute wounds segment is likely to dominate the global market

By end user, the home care centres segment is expected to grow at the fastest pace to reach a CAGR of 4.7% during the forecast period

By region, North America is anticipated to radiate high market attractiveness throughout the forecast period. The wound irrigation systems market in Asia Pacific excluding Japan is projected to grow at a comparatively high rate during 2017-2027

Global Market Study on Wound Irrigation Systems: Competitive Scenario

The research report on the global wound irrigation systems market covers in-depth analysis on various key players participating in the market. Company overview, SWOT analysis, product portfolio, key developments and various growth strategies of major companies such as

Zimmer Biomet
Stryker Corporation
Centurion Medical Products
BSN Medical
Cooper Surgical Inc.
C. R. Bard, Inc.
Medtronic Plc.
Bionix
Westmed, Inc.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3775

Market Segmentation

The global wound irrigation systems market is segmented in detail so as to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Product Type

Manually Operated
Battery Operated

By Wound Type

Acute Wounds
Chronic Wounds

By End User

Hospitals
Ambulatory Surgical Centres
Clinics
Long Term Care Centres
Homecare Settings

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3775

By Region

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa

Oral Solid Dosage Pharmaceutical Formulation Market to Reach US$ 900,000 Billion, Globally, by 2027 at 9.2% CAGR: FMI

Instead of increasing pipeline productivity for biologics and patent cliff challenges, oral solid dosage forms hold substantial opportunity in extending product lifecycle and leveraging growth potential. Manufacturers are employing various life cycle management patent strategies which include obtaining patents on isomers, metabolites, prodrugs, and new drug formulations such as extended, controlled, or rapid release formulations.

Future Market Insights (FMI), in its report, projects the global oral solid dosage pharmaceutical formulation market to register 6.5% CAGR during the forecast period 2017 to 2027. In terms of revenue, the market will reach nearly US$ 500,000 Mn in 2017; by 2027 is further estimated to surpass US$ 900,000 Mn.

North America to Remain Largest Market for Oral Solid Dosage Pharmaceutical Formulation

North America will remain the largest market for oral solid dosage pharmaceutical formulation, followed by Asia Pacific Excluding Japan (APEJ) and Western Europe. Revenue from the market in North America is expected to surpass US$ 300,000 Mn by 2027-end. In addition, APEJ is projected to reach revenue worth US$ 294,750.4 Mn in the market by 2027. Latin America is expected to be the fastest growth region in the market, expanding at 9.2% CAGR through 2027. In contrast, Japan will witness a sluggish growth in the market.

By dosage form, tablets will continue to remain preferred in the market, with sales estimated to surpass US$ 500,000 Mn by 2027-end. Sales of tablets are anticipated to exhibit the highest CAGR in the market, followed by capsules. Capsules are expected to be the second most lucrative dosage form in the market, expanding at 6.1% CAGR through 2027.

To remain ‘ahead’ of your competitors, request for a sample

Immediate Release to Remain Dominant in the Market during 2017-2027

Based on release mechanism, immediate release will remain dominant in the market, expanding at 6.4% CAGR through 2027. Immediate release is expected to generate revenue over US$ 400,000 Mn by 2027-end. Controlled release under extended release segment, is expected to register 7.4% CAGR through 2027.

Retail pharmacy is expected to be the largest end-user of oral solid dosage pharmaceutical formulation market by 2027-end. Retail pharmacy is expected to exhibit highest CAGR in the market through 2027. In contrast, Hospital pharmacy is expected to exhibit lowest CAGR, even though it stands as second largest end-user in the market during the forecast period.

Increasing Presence of MNCs to Drive Market Growth in Latin America

Latin America is emerging as a manufacturing hub for oral solid dosage forms on the back of availability of low-cost resources. Multinational companies are focusing on expanding their presence in this region. These factors are expected to propel market growth in Latin America. Oral solid dosage forms are cost-effective and comparatively easy to manufacture than other dosage forms. They are most commonly used pharmaceuticals for treating various disease conditions in North America, which in turn is driving growth of the market in this region.

Growing effluent consumers in APEJ countries such as China, India and Korea are boosting growth of the oral solid dosage pharmaceutical formulation market in this region. Consumers here are adopting wealthy-life-fast-paced western lifestyle, leading them to suffer western lifestyle-related diseases including diabetes, cancer, and obesity. This compels them in seeking innovative drug treatments, which in turn is expected to fuel market growth in APEJ. However factors such as decreasing productivity of Asian manufacturers and containment issues, and low R&D expenditure coupled with challenges incurred in USFDA compliance are expected to impede growth of the market in APEJ.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2782

Key Players identified in FMI’s report include:

AstraZeneca Plc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Gilead Sciences
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
AbbVie Inc.
Boehringer Ingelheim GmbH
Hoffman-La-Roche Ltd.
Johnson & Johnson
Biogen Inc.
Bayer AG
Teva Pharmaceticals
Amgen Inc.
Takeda Pharmaceutical Company Ltd.
Otsuka Pharmaceutical Co., Ltd.
Shire Plc.
Celgene Corporation
Astellas Pharma Inc.

Market segmentation

By Dosage Form

Tablets
Capsules
Powders
Others

By Drug Release Mechanism

Immediate Release
Extended Release
- Sustained Release
- Controlled Release
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2782

By Region

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa

Endometriosis Treatment Market is expected to exhibit a CAGR of around 3% during the forecast period 2021-2030

Rising prevalence of endometriosis condition has fueled the demand for endometriosis treatment across the world. High focus on the introduction of therapeutically-advanced endometriosis treatment options are expected to propel the growth of the market over the forecast period. Leading industry players are significantly accelerating the development of scientific and clinical therapeutic agents and new product launches in the global endometriosis treatment market. This considerable push by industry players is expected to drive future market growth.

Increasing investments in the endometriosis treatment market by key stakeholders and rising awareness among women are the major factors expected to drive market growth. The global endometriosis treatment market was valued at US$ 2.8 Bn in 2018, and is expected to exhibit a CAGR of around 3% over the forecast period (2019-2030).

“Continuous technological advancements towards the development of non-invasive diagnosis techniques for endometriosis and increasing prevalence of gynecological diseases around the globe are projected to accelerate the growth of the global endometriosis treatment market over the coming years.”

Prominent Players:

AbbVie Inc.
Bayer AG
AstraZeneca
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Ipsen Pharma
Myovant Sciences Ltd
Endoceutics, Inc.
Debiopharm Group
Mayne Pharma Group Limited

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways of Endometriosis Treatment Market Study

Based on drug, oral contraceptives contributed maximum value share to the global endometriosis treatment market in 2018, owing to high preference for them as a first-line therapy for patients without contraindications, and efficacy in preventing recurrence of pelvic pain and endometriosis lesions.

High treatment efficacy and acceptance with low risk are expected to result in notable share of hormonal therapy in the treatment type.

The hospital pharmacies and retail pharmacies segments, collectively, hold above 60% of value share to the endometriosis treatment market, owing to the high patient pool in hospitals and visiting retail pharmacies.

Europe captured a notable revenue share of 37% in 2018, and is expected to be the most lucrative region in the global endometriosis treatment market during the forecast period.

Increasing government expenditure for high growth of the medical industry in emerging economies in the Asian region is expected to drive the growth of the endometriosis treatment market across this region.

Multiple New Indications – Imperative Strategy for Market Players

Increasing the introduction of endometriosis drugs with multiple new indications is a major factor responsible for intense competition among market players. Several companies are focusing on launching new endometriosis treatment options to increase their product sales and expand their market share. For example, in July 2018, AbbVie Inc. introduced a new innovative product – Orilissa™ (elagolix) tablets, a gonadotropin-releasing hormone (GnRH) receptor antagonist for the management of moderate to severe pain associated with endometriosis, in the U.S. market.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3870

What else is in the report?

Future Market Insights (FMI) offers a unique perspective and actionable insights on the endometriosis treatment market in its latest study, presenting historical demand assessment of 2014-2018 and projections for the period of 2019-2030, based on drug (oral contraceptives, progestins, NSAIDs, GnRH analogues, LNR-IUDs, and others), treatment type (hormonal therapy and pain management), and distribution channel (hospital pharmacies, retail pharmacies, drugstores, and e-Commerce), across seven key regions of the world.

Market segmentation

The global endometriosis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug

Oral Contraceptives
Progestins
NSAIDs
GnRH Analogues
LNR-IUDs
Others

Treatment Type

Hormonal Therapy
Pain Management

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drugstores
e-Commerce

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3870

Appendage Management Market Expected to Expand at a CAGR of 6.7% 0ver the Forecast Period of 2021-2028

Providing a detailed assessment of the potential opportunities in atrial fibrillation treatment, Future Market Insights’ recent analysis of the global demand for appendage management showcases a promising future for mechanical appendage closure devices. FMI offers a 10-year assessment, 2018-2028, of the global appendage management market, combined with an analysis of the key market influencers.

“Atrial fibrillation, being one of the most complex condition—increases as the life expectancy increases. Moreover, high mortality and morbidity rates associated with atrial fibrillation, considering the occurrence of embolic events including stroke, is a key major contributing significantly to the appendage management landscape—projected to represent a robust Y-o-Y growth rate of 6.3 percent through 2019, reaching a valuation of approximately US$ 196.2 Million for the same period” predicts a senior healthcare analyst

To remain ‘ahead’ of your competitors, request for a sample

Key Insights on Competitive Landscape Analysis of Global Appendage Management Market

As per the FMI analysis, given the high revenue contribution by top five players—including Boston Scientific Corporation, AtriCure, Inc., Abbott Laboratories, Cardia, Inc., and Medtronic plc—holding an accumulative revenue share of nearly 89 percent, the global appendage management market showcases a highly consolidated landscape. FMI’s research also indicates that smaller players, contribute approximately 11.5 percent revenue share to the global appendage management market. A much more careful competitive landscape analysis of the global appendage management market reveals a 3-tier segmentation—depending upon the growth stage of various companies.

With reach wide enough in North America, Boston Scientific Corporation and AtriCure, Inc. are the clear market leaders—for endocardial and epicardial left atrial closure devices, respectively. With an accumulative share of approximately 57 percent in the appendage management market, Boston Scientific Corporation’s WATCHMAN and AtriCure, Inc.’s products are in direct competition. However, WATCHMAN is most widely implanted and trusted—boasting FDA approval and CE Mark
Mid-stage growth companies including Abbott Laboratories and Cardia, Inc have pulled away from the top two players, in the last few years—holding approximately 32 percent market share. These companies, however, have an expansive range of product offerings. Holding nearly 14 percent in terms of revenue, Abbott Laboratories is upping its portfolio of upper and lower extremities along with popularization of the product with good clinical trial results.
The emerging players, including SentreHEART, Inc., LifeTech Scientific Co., Ltd, Occlutech International AB, and Johnson & Johnson Services, Inc. are more focused on product innovation and differentiation within certain treatment niches, to build a strong market position in the consolidated appendage management landscape. In spite of a miniscule market share, FMI foresees notable potential of their research and development initiatives in the long run.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-7752

In terms of overall forward market strategies, key companies are projected to focus on innovating easily implantable, life-saving products for patients suffering from atrial fibrillation, thereby, eliminating the side-effects caused by drugs taken to treat atrial fibrillation. Innovative devices and better navigation and visualization technologies are expected to bring significant opportunities—translating into increased adoption of Left Atrial Appendage (LAA) closure devices by catheterization laboratories and hospitals.

Moreover, mergers and acquisitions will remain a key expansion strategy among players in appendage management market. FMI indicates that acquisitions in the global appendage management market would prove beneficial for the key leaders considering the increasing number of promising on-going or successful researches by emerging companies. Already in a dominant position, key players are increasingly focusing in strengthening the supply chain and distribution networks through strategic partnerships to maximize their market share.

Competitive Landscape

This section of the report features profiles of key players operating in the appendage management market based on their market shares, differential strategies, product offerings, marketing approach and company dashboard. Some of the key players featured in this report include

Abbott Laboratories
AtriCure, Inc.
Boston Scientific Corporation
Cardia, Inc.
Johnson & Johnson Services, Inc.
LifeTech Scientific Co., Ltd
Medtronic plc.
SentreHEART, Inc.
Occlutech International AB.

Boston Scientific Corporation offers the most trusted product for appendage management, named WATCHMAN device. WATCHMAN device is an endocardial left atrial appendage closure device for occlusion of left atrial appendage. Boston Scientific is launching next-generation WATCHMAN devices with improved and additional features to continue domination in appendage management market.

The key manufacturers of appendage management are focusing on acquisitions and mergers to extend their product portfolio. Launching of new and innovative products is also a strategy followed by the players that is working in their favor.

The companies are conducting conferences and training sessions in hospitals and institutes to enlighten surgeons and practitioners with the improved technology and novel product left atrial appendage closure devices in the appendage management market.

Bonus: Key Market Influencers

Notable success rate of appendage management procedures.
Non-surgical, minimal invasion approach helping in fast recovery and reduced surgical and implantation complications.
Drawback of oral anticoagulant drugs to push the demand for appendage management procedures.

Additional Questions Answered

Some of the additional questions addressed in this report on appendage management market-

What is the revenue potential of epicardial and endocardial left atrial appendage closure device in appendage management market across regions of North America and Europe?
Who are the key competitors and what are their portfolios in appendage management market?
What are major challenges influencing the growth of appendage management market?
How intervention from regulatory authority is shaping the appendage management market growth?

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7752

Segmentation

The report offers a comprehensive taxonomy of the appendage management market based on product type, end user and region. The appendage management market is categorized into two types of products that are epicardial LAA closure devices and endocardial LAA closure devices. These mechanical closure devices in appendage management are used by catheterization and hospitals for appendage management.

Thus, the end-use segments in appendage management market which are a part of this appendage management market report include catheterization laboratories and hospitals. The appendage management market has been analyzed across regions of North America, Latin America, Europe, Asia Pacific (APAC), and MEA.